This information is provided by the National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD).
Intestinal lymphangiectasia is a rare digestive disorder characterized by abnormally enlarged lymph vessels supplying the lining of the small intestine. Affected people may experience intermittent diarrhea, nausea, vomiting, swelling of the limbs and abdominal discomfort. Intestinal lymphangiectasia can be congenital (also called primary intestinal lymphangiectasia or Waldmann disease) in which case it affects children and young adults (mean age of onset, 11 years); it can also be associated with a variety of other conditions and affect older adults. Treatment generally involves control of symptoms with dietary and/or behavioral modifications and the use of certain medications.
For more information, visit GARD.